Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

BMC Medicine
Anne BertrandThierry Schaeverbeke

Abstract

Targeting CTLA-4 is a recent strategic approach in cancer control: blocking CTLA-4 enhances an antitumor immunity by promoting T-cell activation and cytotoxic T-lymphocyte proliferation. This induction of a tolerance break against the tumor may be responsible for immune-related adverse events (irAEs). Our objective was to assess the incidence and nature of irAEs in oncologic patients receiving anti-CTLA-4 antibodies (ipilimumab and tremelimumab). A systematic search of literature up to February 2014 was performed in MEDLINE, EMBASE, and Cochrane databases to identify relevant articles. Paired reviewers independently selected articles for inclusion and extracted data. Pooled incidence was calculated using R(©), package meta. Overall, 81 articles were included in the study, with a total of 1265 patients from 22 clinical trials included in the meta-analysis. Described irAEs consisted of skin lesions (rash, pruritus, and vitiligo), colitis, and less frequently hepatitis, hypophysitis, thyroiditis, and some rare events such as sarcoidosis, uveitis, Guillain-Barré syndrome, immune-mediated cytopenia and polymyalgia rheumatic/Horton. The overall incidence of all-grade irAEs was 72 % (95 % CI, 65-79 %). The overall incidence of high-gr...Continue Reading

References

Apr 2, 1999·Immunology and Cell Biology·K D McCoy, G Le Gros
Mar 4, 2003·Nature Medicine·Thomas A Waldmann
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Oct 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoni RibasJesus Gomez-Navarro
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kimberly E BeckJames C Yang
Apr 6, 2007·The Journal of Clinical Endocrinology and Metabolism·Stephanie A ShawSteven G Waguespack
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Oct 4, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·A EckertL Thomas
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberEvan Hersh
Dec 5, 2008·Cancer Immunology, Immunotherapy : CII·Ilyssa O GordonThomas F Gajewski
Feb 27, 2009·Journal of Immunotherapy·Mojtaba AkhtariMartha L Arellano
May 12, 2009·Immunological Reviews·Hélène Bour-Jordan, Jeffrey A Bluestone
May 29, 2009·AJNR. American Journal of Neuroradiology·K J CarpenterF R Murtagh
Jun 10, 2009·Digestive Diseases and Sciences·James D LordGeorge B McDonald
Jun 11, 2009·Melanoma Research·Katharina C KaehlerAxel Hauschild
Jun 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·David R MinorMohammed Kashani-Sabet
Jul 10, 2009·The New England Journal of Medicine·Fouad FadelBertrand Knebelmann
Aug 5, 2009·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Gary HunterChristopher A Robinson
Feb 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J O'DayJ D Wolchok
Feb 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christy RalphFiona C Thistlethwaite
May 13, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bradley C CarthonPadmanee Sharma
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ki Y ChungLeonard B Saltz
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 16, 2010·Seminars in Oncology·Luana CalabròMichele Maio
Nov 20, 2010·European Journal of Endocrinology·Le MinCarolyn Becker
Dec 15, 2010·Current Opinion in Oncology·Marna G BouwhuisAlexander Mm Eggermont
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katarzyna D ChmielRichard Kefford
Jan 26, 2011·Medical Oncology·Zachary R BarnardJean Valery Coumans
Mar 2, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Wilgenhof, B Neyns
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Aug 3, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·S AhmadM Iddawela

❮ Previous
Next ❯

Citations

Mar 17, 2016·Journal for Immunotherapy of Cancer·Viktor H KoelzerKirsten D Mertz
Apr 14, 2016·Ocular Immunology and Inflammation·Emmett T CunninghamManfred Zierhut
Apr 28, 2016·Joint, Bone, Spine : Revue Du Rhumatisme·Jean-Hugues SalmonFlorent Grange
May 5, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Philip SargesJames H Lewis
Jul 18, 2016·Journal of the Neurological Sciences·W GrisoldW N Löscher
Jul 1, 2016·Dermatologic Therapy·L Martínez LeboránsA Berrocal Jaime
Jul 5, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Katharina C KählerUNKNOWN für das Komitee „Kutane Nebenwirkungen“ der Arbeitsgemeinschaft Dermatologische Onkologie (ADO)
Jul 5, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Katharina C KählerUNKNOWN “Cutaneous Side Effects” Committee of the Work Group Dermatological Oncology (ADO)
Aug 16, 2016·Transfusion Medicine Reviews·Bernard Khor
Aug 16, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D Kee, G McArthur
Sep 9, 2016·Brain : a Journal of Neurology·Lidia M YshiiRoland Liblau
Jul 7, 2016·Clinical & Experimental Metastasis·Omar FahmyGeorgios Gakis
Nov 12, 2016·The Journal of Allergy and Clinical Immunology. in Practice·Jolan E WalterMegan A Cooper
Dec 21, 2016·Immunotherapy·Pierpaolo CorrealePierosandro Tagliaferri
Dec 3, 2016·The Journal of Allergy and Clinical Immunology·Alexander A NavariniMike Recher
Jan 14, 2017·Arthritis & Rheumatology·Maria E Suarez-AlmazorAdi Diab
Mar 24, 2017·Journal of Cellular Biochemistry·Michael Dougan, Stephanie K Dougan
Apr 20, 2017·Der Pathologe·V H KoelzerK D Mertz
May 26, 2017·Neurologia Medico-chirurgica·Eiichi IshikawaAkira Matsumura
May 27, 2017·Cancer Investigation·Giorgos BamiasHelen Gogas
Apr 28, 2017·Expert Opinion on Biological Therapy·Mariela A Moreno AyalaMarianela Candolfi
Dec 30, 2016·Journal for Immunotherapy of Cancer·Andrew S BrohlJeffrey S Weber
Jan 20, 2017·Pathology Oncology Research : POR·Lidia KarabonI Frydecka
Mar 30, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liu YangSheng Hu
Apr 22, 2017·Journal for Immunotherapy of Cancer·Matthew J ReilleyDavid S Hong
Mar 18, 2017·Current Opinion in Oncology·Nicole N DavarpanahAndrea B Apolo
Mar 8, 2018·Nature Reviews. Gastroenterology & Hepatology·Mark A SamaanPeter M Irving
Feb 19, 2016·Inflammatory Bowel Diseases·Karen A Chachu, Mark T Osterman
Mar 2, 2018·Human Vaccines & Immunotherapeutics·Audrey Humphries, Adil Daud
Feb 28, 2018·Melanoma Research·Florentia DimitriouJoanna Mangana
Nov 28, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Nam Q Bui, Shivaani Kummar
Nov 23, 2017·Journal for Immunotherapy of Cancer·I PuzanovUNKNOWN Society for Immunotherapy of Cancer Toxicity Management Working Group
Dec 1, 2017·Journal of Clinical Neuromuscular Disease·Songkit Supakornnumporn, Bashar Katirji

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Software Mentioned

R
Meta

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.